Citius Pharmaceuticals, Inc. (CTXR) Total liabilities 2017–2022
Citius Pharmaceuticals, Inc. (CTXR) total liabilities at each fiscal year-end, per SEC filings.
$10.6MFY2022 · since FY2017: $2.5M → $10.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2022 | $10.6M | +9.6% |
| FY2021 | $9.6M | -4.5% |
| FY2020 | $10.1M | +5.3% |
| FY2019 | $9.6M | +2236.2% |
| FY2018 | $410,640 | -83.4% |
| FY2017 | $2.5M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice